Stock listing
NASDAQ:GNLX Genelux Corporation Stock
Home listing (NASDAQ) of Genelux Corporation
Follow Genelux Corporation into a list and get an email when it puts out news.
Share price · NASDAQ:GNLX
$1.92 USD -0.08 (-4.0%)
Close on Nov 3, 2026
- Day range
- $1.91 – $2.07 USDNov 3, 2026
- Volume
- 287,998 sharesNov 3, 2026
- Market cap
- $86.87M USDAt the close on Nov 3, 2026 · price × 45.25M shares outstanding
- 52-week range
- $1.86 – $8.54 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $869,828 USDMedian day 295,907 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GNLX · Home | $1.92 USD | -0.08 (-4.0%) | 287,998 | $2.01 | $2.065 | $1.91 | $2.00 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NASDAQ:GNLX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.92 | -0.08 | -4.0% | $2.01 | $2.065 | $1.91 | 287,998 | |
| $2.00 | -0.08 | -3.8% | $2.11 | $2.18 | $1.952 | 523,901 | |
| $2.08 | -0.02 | -1.0% | $2.07 | $2.11 | $2.00 | 209,629 | |
| $2.10 | -0.11 | -5.0% | $2.27 | $2.27 | $2.085 | 120,301 | |
| $2.21 | +0.16 | +7.8% | $2.06 | $2.24 | $1.98 | 523,908 | |
| $2.05 | +0.14 | +7.3% | $1.92 | $2.07 | $1.86 | 1,451,693 | |
| $1.91 | -0.09 | -4.5% | $2.00 | $2.12 | $1.87 | 494,700 | |
| $2.00 | +0.02 | +1.0% | $2.02 | $2.07 | $1.90 | 648,745 | |
| $1.98 | -0.09 | -4.3% | $2.04 | $2.35 | $1.96 | 947,444 | |
| $2.07 | -0.43 | -17.2% | $2.53 | $2.57 | $2.018 | 850,725 | |
| $2.50 | +0.05 | +2.0% | $2.43 | $2.612 | $2.43 | 331,726 | |
| $2.45 | +0.03 | +1.2% | $2.42 | $2.47 | $2.40 | 161,491 | |
| $2.42 | -0.06 | -2.4% | $2.48 | $2.52 | $2.355 | 277,873 | |
| $2.48 | +0.16 | +6.9% | $2.40 | $2.51 | $2.33 | 796,526 | |
| $2.32 | -0.20 | -7.9% | $2.48 | $2.52 | $2.32 | 410,559 | |
| $2.52 | -0.025 | -1.0% | $2.53 | $2.54 | $2.485 | 151,876 | |
| $2.545 | -0.015 | -0.6% | $2.59 | $2.59 | $2.51 | 72,617 | |
| $2.56 | +0.06 | +2.4% | $2.48 | $2.57 | $2.47 | 154,650 | |
| $2.50 | -0.02 | -0.8% | $2.47 | $2.53 | $2.42 | 259,115 | |
| $2.52 | -0.02 | -0.8% | $2.52 | $2.59 | $2.46 | 550,979 | |
| $2.54 | -0.06 | -2.3% | $2.58 | $2.63 | $2.52 | 77,647 | |
| $2.60 | +0.04 | +1.6% | $2.55 | $2.66 | $2.465 | 317,345 | |
| $2.56 | +0.04 | +1.6% | $2.55 | $2.59 | $2.515 | 278,256 | |
| $2.52 | -0.01 | -0.4% | $2.53 | $2.56 | $2.46 | 200,900 | |
| $2.53 | +0.08 | +3.3% | $2.47 | $2.55 | $2.47 | 236,870 | |
| $2.45 | -0.02 | -0.8% | $2.48 | $2.56 | $2.415 | 164,897 | |
| $2.47 | -0.01 | -0.4% | $2.46 | $2.50 | $2.41 | 103,751 | |
| $2.48 | +0.05 | +2.1% | $2.47 | $2.54 | $2.42 | 139,873 | |
| $2.43 | -0.085 | -3.4% | $2.51 | $2.524 | $2.41 | 151,993 | |
| $2.515 | -0.095 | -3.6% | $2.61 | $2.64 | $2.50 | 115,792 | |
| $2.61 | +0.05 | +2.0% | $2.55 | $2.63 | $2.52 | 161,803 | |
| $2.56 | +0.03 | +1.2% | $2.57 | $2.585 | $2.51 | 197,287 | |
| $2.53 | 0.00 | 0.0% | $2.54 | $2.565 | $2.504 | 143,118 | |
| $2.53 | +0.19 | +8.1% | $2.36 | $2.56 | $2.36 | 295,280 | |
| $2.34 | -0.13 | -5.3% | $2.47 | $2.47 | $2.31 | 661,722 | |
| $2.47 | -0.07 | -2.8% | $2.61 | $2.61 | $2.40 | 203,404 | |
| $2.54 | +0.05 | +2.0% | $2.49 | $2.61 | $2.46 | 297,586 | |
| $2.49 | +0.01 | +0.4% | $2.53 | $2.55 | $2.448 | 146,907 | |
| $2.48 | -0.04 | -1.6% | $2.55 | $2.73 | $2.41 | 535,584 | |
| $2.52 | -0.02 | -0.8% | $2.50 | $2.555 | $2.485 | 114,099 | |
| $2.54 | +0.10 | +4.1% | $2.50 | $2.54 | $2.39 | 408,292 | |
| $2.44 | -0.08 | -3.2% | $2.52 | $2.535 | $2.425 | 296,534 | |
| $2.52 | -0.03 | -1.2% | $2.55 | $2.58 | $2.46 | 510,440 | |
| $2.55 | -0.05 | -1.9% | $2.58 | $2.635 | $2.55 | 158,137 | |
| $2.60 | -0.015 | -0.6% | $2.63 | $2.66 | $2.56 | 194,989 | |
| $2.615 | -0.045 | -1.7% | $2.67 | $2.77 | $2.56 | 328,487 | |
| $2.66 | -0.22 | -7.6% | $2.87 | $2.87 | $2.65 | 417,797 | |
| $2.88 | +0.15 | +5.5% | $2.72 | $2.95 | $2.72 | 594,425 | |
| $2.73 | +0.01 | +0.4% | $2.73 | $2.756 | $2.64 | 300,182 | |
| $2.72 | 0.00 | 0.0% | $2.73 | $2.82 | $2.67 | 352,906 | |
| $2.72 | 0.00 | 0.0% | $2.70 | $2.77 | $2.57 | 361,056 | |
| $2.72 | -0.02 | -0.7% | $2.78 | $2.81 | $2.684 | 223,747 | |
| $2.74 | +0.06 | +2.2% | $2.72 | $2.80 | $2.62 | 405,118 | |
| $2.68 | +0.08 | +3.1% | $2.64 | $2.79 | $2.63 | 317,437 | |
| $2.60 | -0.10 | -3.7% | $2.70 | $2.79 | $2.555 | 379,006 | |
| $2.70 | -0.04 | -1.5% | $2.76 | $2.76 | $2.63 | 265,149 | |
| $2.74 | +0.11 | +4.2% | $2.65 | $2.82 | $2.58 | 462,788 | |
| $2.63 | -0.07 | -2.6% | $2.70 | $2.76 | $2.61 | 315,709 | |
| $2.70 | +0.05 | +1.9% | $2.70 | $2.73 | $2.54 | 250,836 | |
| $2.65 | -0.07 | -2.6% | $2.75 | $2.775 | $2.55 | 315,950 | |
| $2.72 | +0.06 | +2.3% | $2.66 | $2.73 | $2.62 | 434,431 | |
| $2.66 | -0.04 | -1.5% | $2.72 | $2.72 | $2.52 | 246,863 | |
| $2.70 | +0.19 | +7.6% | $2.51 | $2.735 | $2.50 | 209,650 | |
| $2.51 | -0.31 | -11.0% | $2.85 | $2.93 | $2.50 | 950,188 | |
| $2.82 | -0.16 | -5.4% | $3.00 | $3.08 | $2.78 | 787,371 | |
| $2.98 | +0.04 | +1.4% | $2.97 | $2.99 | $2.91 | 219,562 |
- Ticker
- NASDAQ:GNLX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 9, 2026
Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 46 slides
Latest news
Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy
Sep 9, 2026
Closed $2.48 (-1.6%) on Sep 10, 2026
Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
Aug 13, 2026
Closed $2.74 (+4.2%) on Aug 14, 2026
Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer
Jun 30, 2026
Closed $3.01 (+3.8%) on Jun 30, 2026
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
May 7, 2026
Closed $3.11 (+9.9%) on May 8, 2026
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar 19, 2026
Closed $2.40 (-5.5%) on Mar 20, 2026
Genelux Corporation to Participate in Upcoming Conferences
Feb 18, 2026
Closed $2.62 (+2.3%) on Feb 18, 2026
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
Jan 12, 2026
Closed $2.74 (+3.4%) on Jan 13, 2026
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
Jan 8, 2026
Closed $2.72 (-19.8%) on Jan 8, 2026
Genelux Corporation Announces Proposed Public Offering of Common Stock
Jan 7, 2026
Closed $2.72 (-19.8%) on Jan 8, 2026
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
Jan 5, 2026
Closed $3.48 (-23.5%) on Jan 5, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 46 slides · August 2026
Investor Presentation (February 2026)
Investor deck · 45 slides · Feb 2, 2026
Investor Presentation (March 2025)
Investor deck · 43 slides · Mar 25, 2025
Investor Presentation (November 2024)
Investor deck · 41 slides · Nov 8, 2024
Genelux Corporation on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 41 in all · newest Sep 9, 2026 · oldest 2023
- Decks
- 17 decks · latest August 2026
Where Genelux Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GNLX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:GNLX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Genelux Corporation.